BUZZ-Tekmira Pharmaceuticals Corp: Offering priced at discount

Fri Mar 20, 2015 11:07am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian biopharmaceutical company's U.S.-listed stock down 2.5 pct at $19.98

** More than 3 million shares changed hands by 10:58 ET, nearly thrice their 50-day moving average

** Company's offering of 7.5 mln shares priced at $20.25 per share, a discount of 1.1 pct to Thursday's close of $20.49

** Says aggregate gross proceeds of $151.9 mln before deducting underwriting discounts and commissions and other offering expenses

** Up to Thursday's close, stock had fallen nearly 18 pct in the past 12 months on the Nasdaq